|
Volumn 64, Issue 9, 2012, Pages 3057-3058
|
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI PROTEINASE 3;
CD20 ANTIBODY;
CREATININE;
ENZYME ANTIBODY;
UNCLASSIFIED DRUG;
ANCA ASSOCIATED VASCULITIS;
CARDIOVASCULAR RISK;
CREATININE BLOOD LEVEL;
DISEASE ASSOCIATION;
FOLLOW UP;
HUMAN;
KIDNEY FAILURE;
LETTER;
PRIORITY JOURNAL;
RELAPSE;
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS;
ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC;
CREATININE;
FEMALE;
HUMANS;
MALE;
|
EID: 84865651802
PISSN: 00043591
EISSN: 15290131
Source Type: Journal
DOI: 10.1002/art.34590 Document Type: Letter |
Times cited : (3)
|
References (6)
|